FDA OKs Marketing of New Device to Reduce Snoring, Mild OSA

MONDAY, Feb. 8, 2021 -- A new device to reduce snoring and mild obstructive sleep apnea has received marketing authorization by the U.S. Food and Drug Administration, the agency announced Friday. The eXciteOSA device, available only by prescription...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news